Durvalumab,Tremelimumab
Astrazeneca,Pfizer
['biomarker', 'rectal', 'colorectal', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)']
at #asco23 today #cctg analysis of co26 trial plasma arginine as a candidate predictive biomarker for response to immune checkpoint inhibition (ici) in metastatic colorectal cancer (mcrc) poster session 3545: 
The Canadian Cancer Trials Group is a cancer clinical trials research cooperative that runs phase I-III trials to test anti-cancer and supportive therapies.